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Since the first report of blaNDM-1, 16 blaNDM variants have been identified among
Gram-negative bacteria worldwide. Recently, a novel blaNDM variant, blaNDM-13, was
identified in the chromosome of an ST101 Escherichia coli isolate from Nepal. Here we
first reported plasmid-mediated blaNDM-13 in a carbapenem-resistant E. coli ST5138
clinical isolate associated with hospital-acquired urinary tract infection from China.
blaNDM-13 and blaSHV-12 coexisted on the a∼54 Kb self-transferable plasmid. Compared
with NDM-1, NDM-13, NDM-3, and NDM-4 had two amino acid substitutions (D95N
and M154L), one amino acid substitution (D95N) and one amino acid substitutions
(M154L), respectively. Complete plasmid sequencing showed that blaNDM-13-harboring
plasmid (pNDM13-DC33) was highly similar to the blaNDM-1-harboring IncX3 plasmid
pNDM-HN380, a common blaNDM-harboring vector circulating in China. In accordance
with the structure of pNDM-HN380, pNDM13-DC33 consists of a 33-kb backbone
encoding plasmid replication (repB), stability partitioning, and transfer (tra, trb, and
pil) functions, and a 21-kb antimicrobial resistance region with high GC content
between umuD and mpr genes. In conclusion, the present study is the first report of
a plasmid-encoded blaNDM-13 and the complete sequence of a blaNDM-13-harboring
plasmid (pNDM13-DC33). blaNDM-13 maybe originate from blaNDM-1 located on a
pNDM-HN380-like plasmid by sequential mutations.
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INTRODUCTION
Enterobacteriaceae, particularly Escherichia coli and Klebsiella pneumioniae, are common
pathogens causing nosocomial infections. Carbapenems are the choice for the treatment of
infections caused by multi-drug resistant Enterobacteriaceae, especially extended-spectrum β
lactamase (ESBL)- and/or plasmid-mediated AmpC (pAmpC)-producing organisms (Tzouvelekis
et al., 2012). The emergence of carbapenem-resistant K. pneumonia and E. coli producing
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carbapenemases (KPCs) and metallo-β-lactamases (MBLs) have
become a major global health problem due to the limited number
of effective antibiotic options to treat the infections caused
by these multi-drug resistant Enterobacteriaceae (Tzouvelekis
et al., 2012). In 2009, a novel MBL, named New Delhi metallo-
β-lactamase-1 (NDM-1), was identified in a K. pneumoniae
isolate from a Swedish patient who had returned from
India with a urinary tract infection (Yong et al., 2009).
Since then, NDM-1-producing Gram-negative isolates have
emerged worldwide. NDM-1 was primarily identified in
Enterobacteriaceae, especially in E. coli and K. pneumoniae, from
the Indian subcontinent, Balkan states, the Arabian peninsula,
and North Africa (Nordmann and Poirel, 2014). In China, NDM-
1 was initially identified in 4 clonally unrelated Acinetobacter
baumannii isolates in 2011(Chen et al., 2011). Subsequently, this
clinically important enzyme has spread among many species of
Enterobacteriaceae in China (Hu et al., 2013; Liu et al., 2013;
Zhang et al., 2013).
Since the first report of NDM-1, 16 NDM variants have been
identified among Gram-negative bacteria worldwide (http://
www.ncbi.nlm.nih.gov/pathogens/submit_beta_lactamase/).
Recently, a novel NDM variant, NDM-13, was reported in a
multidrug-resistant E. coli clinical isolate in Nepal (Shrestha
et al., 2015). The blaNDM-13 gene, interestingly, was found to
locate within the chromosome of an E. coli ST101 isolate. The aim
of the present study was to investigate whether blaNDM-13 was
located on the plasmids of clinically isolated Enterobacteriaceae.
We first found plasmid-mediated blaNDM-13 and completely
sequenced a blaNDM-13-harboring plasmid for the first time from
a carbapenem-resistant E. coli ST5138 clinical isolate associated
with hospital-acquired urinary tract infection in China.
MATERIALS AND METHODS
Bacterial Strain
From Mar, 2014 to Oct, 2014, a total of 87 carbapenem-resistant
Enterobacteriaceae (CRE) isolates causing clinical infections
isolated from various specimens of patients at the First Affiliated
Hospital of Wenzhou Medical University in Wenzhou, east
China, were investigated for carbapenemase genes. The isolates
were identified as E. coli by an automated microbiology analyzer
(bioMe’rieux, Marcy l’Etoile, France) in accordance with the
manufacturer’s instructions.
Antimicrobial Susceptibility Testing
Gram-negative susceptibility (GNS) card on the Vitek system
(bioMe’rieux, Marcy l’Etoile, France) was performed initially for
antimicrobial susceptibility testing. Disk diffusion method was
used for further confirmation and antimicrobial susceptibility
results were interpreted according to the criteria recommended
by Clinical and Laboratory Standards Institute (CLSI) (CLSI,
2014). The E-test method was used for the determination
of minimum inhibitory concentrations (MICs) of imipenem
and meropenem for the E. coli isolate and its transconjugant.
E. coli ATCC 25922 was used as control strain for antimicrobial
susceptibility testing.
Detection of Carbapenemases and
Extended-Spectrum β-Lactamases (ESBLs)
The modified Hodge test (MHT) was further performed on
a Mueller-Hinton agar plate with ertapenem as substrate for
the detection of carbapenemases as described previously(CLSI,
2014). MBLs were determined using a double-disc synergy
test (Peleg et al., 2005). ESBLs were tested using the CLSI-
recommended confirmatory double disk combination(CLSI,
2014).
Detection of Resistance Genes
The carbapenemase genes responsible for carbapenem resistance,
including blaKPC, blaGES, blaSPM, blaIMP, blaVIM, blaSPM, and
blaNDM, were detected using PCR and DNA sequencing as
described previously (Queenan and Bush, 2007; Nordmann
et al., 2011). ESBLs genes were detected in accordance with
the method described previously (Andrade et al., 2010). PCR
products were analyzed by electrophoresis in 1% agarose gels and
were sequenced on both strands.
Transferability of Plasmids with
Carbapenem Resistance
In order to determine whether carbapenem resistance was
transferable in E.coli DC33 strain, filter mating conjugation
was performed using E. coli 600 as the recipient as previously
described (Wang et al., 2004). Plasmid DNA of E. coli DC33
strain was extracted with the QIAGENPlasmid Midi kit (Hilden,
Germany) according to the manufacturer’s instructions. The
plasmid extracts were transferred into E. coli DH5α by using
chemical transformation and transformants were selected on
Luria-Bertani agar plates containing imipenem (0.5µg/ml).
Multi-Locus Sequence Typing (MLST)
Multi-Locus Sequence Typing (MLST) was performed on E. coli
DC33 using amplification of internal fragments of the seven
housekeeping genes including adk, fumC, gyrB, icd, mdh, purA,
and recA of E. coli according to MLST website (http://mlst.
warwick.ac.uk/mlst/dbs/Ecoli).
Determination of blaNDM-13 Location
The total bacterial DNA of E. coli DC33 was first prepared
in agarose plugs, digested with S1 nuclease and further
separated by pulsed-field gel electrophoresis (PFGE), as described
previously(Chen et al., 2011). Then, the DNA bands were
transferred horizontally to a nylon membrane (Millipore). A
digoxigenin-labeled blaNDM-13 probe was used to hybridize with
DNA bands and a nitro-blue tetrazolium/5-bromo-4-chloro-3′-
indolylphosphate color detection kit (Roche Applied Sciences)
was applied to detected hybridization signals.
Sequencing a blaNDM-13-Harboring Plasmid
from the Transconjuguant of E. Coli DC33
Strain
In order to completely characterize the plasmid from the
transconjugant of E. coli DC33 (designated as pNDM13-DC33),
pNDM13-DC33 was isolated, purified, and sequenced using the
Illumina MiSeq platform. The sequencing reads were de novo
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assembled, gaps between contigs were closed, open reading
frames (ORFs) were predicted, and annotations were performed
as described previously (Chen et al., 2013).
RESULTS AND DISCUSSION
Carbapenemases and ESBLs Production
and Detection of Resistance Genes
Among 87 CRE isolates, 7 were positive for blaNDM. After
sequencing, E. coli strain DC33 was found to harbor blaNDM-13.
E. coli strain DC33 was isolated from a urine culture of a 64-
year-old male hospitalized for prostatic hyperplasia in July, 2014.
After hospitalized, the patient had the symptom of urinary tract
infection. Subsequently, many white cells were found in urine
sample under microscope. E. coli strain DC33 was isolated when
the patient was hospitalized on day 8. E. coli DC33 was weakly
positive for theMHT assay, but β-lactamase activity was inhibited
by EDTA, indicating that E. coli DC33 produced a MBL. E. coli
DC33 was also positive for CLSI-recommended confirmatory
double disk combination test for detecting ESBLs. The results
of detection of ESBL genes using PCR showed that E. coli
DC33 was also positive for blaSHV while was negative for other
resistance genes tested. After DNA sequencing, blaSHV was found
to blaSHV-12.
Antimicrobial Susceptibility Testing
Escherichia coli DC33 exhibited resistance to all antimicrobials
tested except tigecycline determined initially by Gram-
negative susceptibility (GNS) card on the Vitek system
(Table 1), including ampicillin, ampicillin/sulbactam, amikacin,
aztreonam, cefotetan, ceftazidme, ceftriaxone, cefepime,
ciprofloxacin, ertapenem, gentamicin, imipenem, levofloxacin,
nitrofurantoin, piperacillin/tazobactam, tobramycin, and
trimethoprim/sulfamethoxazole, The E. coli IOMTU558
carrying blaNDM-13 located on the chromosome from Nepal
was highly resistant to all β lactams tested including ampicillin,
ampicillin/sulbactam, cefepime, cefoselis, cefotaxime, cefoxitin,
cefpirome, ceftazidime, ceftriaxone, cephradine, doripenem,
imipenem, meropenem, and moxalactam(Shrestha et al.,
2015). The E. coli IOMTU558 was also resistant to other
antibiotics including ciprofloxacin, gentamicin, kanamycin,
levofloxacin, and tobramycin, but susceptible to amikacin,
colistin, fosfomycin, and minocycline (Shrestha et al., 2015).
Tigecycline MICs for E. coli DC33 and E. coli IOMTU558 were
0.05 and 2µg/ml (Shrestha et al., 2015). The antimicrobial
susceptibility pattern of E. coli DC33 was further confirmed
by disk diffusion method. The resistance of E. coli DC33 to
imipenem and meropenem was further corroborated by E-test
method.
MLST
MLST result showed E. coli DC33 belonged to ST5138, a single
locus variant of ST617. Although ST5138 has been deposited
in E. coli MLST database (http://mlst.warwick.ac.uk/mlst/dbs/
Ecoli), no study about E. coli ST5138 isolate is published. In
our previous study, coexistence of blaNDM-1 and blaCMY-42
was found among E. coli ST167 clinical isolates in our hospital
TABLE 1 | MIC values of antimicrobials for E. coli DC33
carrying blaNDM-13 and its transconjugant.
Antimicrobials MIC values (µg/mL)
DC33 DC33-EC600 EC600
Ampicillin ≥32 ≥32 16
Ampicillin/Sulbactam ≥32 ≥32 4
Piperacillin/Tazobactam ≥128 ≥128 ≤4
Cefotetan ≥64 ≥64 ≤4
Ceftazidime ≥64 ≥64 ≤1
Ceftriaxone ≥64 ≥64 ≤1
Cefepime ≥64 16 ≤1
Aztreonam ≥64 ≥64 ≤1
Ertapenem ≥8 ≥8 ≤0.5
Imipenem ≥16 ≥16 ≤1
Amikacin ≥64 ≤2 ≤2
Gentamicin ≥16 ≤1 ≤1
Tobramycin ≥16 ≤1 ≤1
Ciprofloxacin ≥4 2 ≤0.25
Levofloxacin ≥8 4 ≤0.5
Nitrofurantoin 64 64 ≤16
Trimethoprim/Sulfamethoxazole ≥320 ≤20 ≤20
Tigecycline 0.05 0.05 0.05
(Zhang et al., 2013). As ST5138 was a single-locus variant of
S167, we speculate that E. coli DC33 harboring blaNDM-13 is
genetically related to E. coli ST 167 isolates carrying blaNDM-1
found in our previous study (Zhang et al., 2013). Recently, a
Chinese study found an increasing prevalence of E. coli ST167
clinical isolates carrying both blaNDM-1 and blaNDM-5 on the
conjugative IncX3 plasmid in various parts of China (Huang
et al., 2016). Therefore, increasing emergence of blaNDM variants
among E. coli ST167 and ST167 variants clinical isolates should
be of concern. Up to now, blaNDM-13 was only reported in
Nepal(Shrestha et al., 2015). The present study is the second
report of this novel blaNDM variant.
Location of blaNDM-13 Gene and
Transferability of Plasmids Carrying
blaNDM-13
S1-PFGE result showed that a ∼54-Kb plasmid was found in E.
coli DC33 (Figure 1). Subsequently, blaNDM-13 gene was found
to be located on this plasmid, not on chromosome, which
was confirmed by Southern-blot (Figure 1). The blaNDM-13-
harboring plasmid of E. coli DC33, designated as pNDM13-
DC33, was successfully transferred into recipient E. coli 600 by
filter mating conjugation. The antimicrobial resistance patterns
of E. coli DC33 and its transconjugant were showed in Table 1.
Shrestha et al found that blaNDM-13 was located within the
chromosome(Shrestha et al., 2015). However, blaNDM-13 was first
confirmed to be located on the plasmid in the present study.
Complete Sequence of pNDM13-DC33
Plasmid pNDM13-DC33 is 54.035-bp in length, with an average
GC content of 49.03% (Figure 2). BLASTn analysis showed that
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pNDM13-DC33 is similar to pNDM-HN380, an IncX3-type
plasmid carrying blaNDM-1 among Enterobacteriaceae isolates in
China (Ho et al., 2012), with 100% query coverage and >99.9%
FIGURE 1 | S1-digested plasmid DNA of E. coli DC33 (A). Southern blot
hybridization with blaNDM-13 of E. coli DC33 (B). M, Salmonella serotype
Braenderup strain H9812.
nucleotide identity (with 8 single nucleotide polymorphisms,
SNPs). In China, IncX3-type plasmids carrying blaNDM variants
have been widely found among E. coli clinical isolates with
different clones including ST648, ST156, ST131, ST167, and
ST3835 clones (Feng Y. et al., 2015; Huang et al., 2016;
Wang et al., 2016; Yang et al., 2016). Notably, these similar
plasmids have been identified in several hospitals from different
geographic regions in China (Wang et al., 2014; Feng J.
et al., 2015; Qu et al., 2015), suggesting that pNDM-HN380-
like plasmids are common NDM vectors that likely contribute
significantly to the dissemination of blaNDM variants in China.
In accordance with the structure of pNDM-HN380,
pNDM13-DC33 consists of a 33-kb backbone encoding
plasmid replication (repB), stability partitioning, and transfer
(tra, trb, and pil) functions, and a 21-kb antimicrobial resistance
region with comparatively high GC content between umuD
and mpr genes, suggesting that these two regions were likely
acquired and genetically distinct. The resistance region of
pNDM13-DC33, containing 16 ORFs sequentially organized as
IS26, blaSHV-12, ygbI, ygbJ, IS26, insE, groL, cutA1, dsbc, ∆trpF,
bleMBL, blaNDM-13, 1ISAba125, IS5, 1ISAba125, and Tn3 tnpA,
was nearly identical to that of pNDM-HN380, but with the
exception that they carry different blaNDM variants (pNDM13-
DC33 with blaNDM-13 and pNDM-HN380 with blaNDM-1)
(Figure 2). Of note, compared with NDM-1, NDM-13, NDM-3,
and NDM-4 had two amino acid substitutions (D95N and
M154L), one amino acid substitution (D95N) and one amino
acid substitutions (M154L), respectively (Table 2). Although
NDM-13 (with two substitutions including the D95N and
M154L relative to NDM-1) did not show increased hydrolytic
activity against carbapenems, cephalosporins, and penicillins,
it increased the affinity of NDM-13 for cefotaxime and affected
the catalytic activity of the enzyme against cefotaxime (Shrestha
et al., 2015). Our finding that blaNDM-13-harboring pNDM13-
DC33 closely resembles blaNDM-1-harboring pNDM-HN380
provides evidence that novel blaNDM variants emerge by
sequential mutations of a pNDM-HN380-like plasmid carrying
blaNDM-1.
FIGURE 2 | Plasmid structures of pNDM_HN380 (JX104760), pNDM13_DC33(KX094555) and the blaNDM-13 neighboring genetic environment in
IOMTU558 (LC012596). Colored arrows represent open reading frames, with dark blue, yellow, green, red, light blue, and orange arrows representing replication
genes, mobile elements, plasmid transfer genes, resistancegenes, IS5, and plasmid backbone genes, respectively. Blue shading denotes regions of shared homology
among different plasmids.
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NDM-5 G262T, A460C V88L, M154L
NDM-6 C698T A233V
NDM-7 G388A, A460C D130N, M154L
NDM-8 A389G, A460C D130G, M154L
NDM-9 G454A E152K





NDM-12 A460C, G665A M154L, G222D
NDM-13 G283A, A460C D95N, M154L
NDM-14 A389G D130G
NDM-15 A460C, G698T M154L, A233V
NDM-16 G262C, A460C, G698T V88L, M154L, A233V
*Nucleotide and amino acid positions (in comparison to NDM-1) of nonsynonymous
substitutions were listed. Amino acid abbreviations follow the standard single letter code.
The chromosomal organization of the blaNDM-13 gene initially
found in the E. coli isolate IOMTU558 from Nepal was similar
to that in pNDM13-DC33, except for a 260-bp deletion in
ISAba125 of 260 bp (353 to 94 bp upstream blaNDM-13 start
codon). In contrast, the corresponding ISAba125 on pNDM13-
DC33 was in full-length (1087 bp), but was interrupted by the
insertion of an IS5 (at 265 bp upstream blaNDM-13 start codon)
(Figure 1). A comparison of the chromosomal organization
flanking blaNDM-13 in the E. coli isolate IOMTU558 (Shrestha
et al., 2015) with plasmids harboring blaNDM identified the a
set of ordered genes, tnpA-IS30-blaNDM-13-bleMBL-trpF-dsbC-
cutA-groES-groL, that were nearly identical in plasmid pPMK1
fromNepal, plasmidpKPX-1 fromTaiwan, plasmid pNDM-MAR
from Morocco, and in an Enterobacter hormaechei CCHB10892
plasmid from Brazil (Villa et al., 2012; Huang et al., 2013;
Carvalho-Assef et al., 2014; Stoesser et al., 2014; Shrestha et al.,
2015). This finding suggests that the chromosomal copy of
blaNDM-13 may be the result of a rare integration event where a
region of the plasmid recombined into the E. coli genome.
In conclusion, the present study is the first report of a
plasmid-encoded blaNDM-13 and the complete sequence of
a blaNDM-13-harboring plasmid (pNDM13-DC33). blaNDM-13
maybe originate from blaNDM-1 located on a pNDM-HN380-
like plasmid by sequential mutations. The emergence of novel
plasmid-mediated blaNDM variants, originating through the
mutations in blaNDM from an epidemic plasmid, poses a concern
that NDM variants with different β-lactamases hydrolytic activity
will evolve.
Nucleotide Sequence Accession Number
The complete nucleotide sequences of plasmid pNDM13-DC33
has been deposited as GenBank accession no. KX094555.
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